| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/29/2009 | WO2009012590A1 Therapeutic formulations for the treatment of cold and flu-like symptoms |
| 01/29/2009 | WO2008149177A3 Marine lipid compositions and uses thereof |
| 01/29/2009 | WO2008109368A4 Nucleic acid compounds for inhibiting vegfr gene expression and uses thereof |
| 01/29/2009 | WO2008104175A3 Novel phosphodiesterase inhibitors |
| 01/29/2009 | WO2008063781A3 Chemical compounds as cannabinoid receptor ligands |
| 01/29/2009 | US20090030078 Therapeutic agent for pain |
| 01/29/2009 | US20090030072 Pharmaceutical combination of opioid and prostaglandin compound |
| 01/29/2009 | US20090030061 Benzoisoindole Derivatives And Their Use As EP4 Receptor Ligands |
| 01/29/2009 | US20090030051 Inhibitors of IMPDH enzyme |
| 01/29/2009 | US20090030037 Sustained Release Formulation and Dosing Schedules of Leukotriene Synthesis Inhibitor for Human Therapy |
| 01/29/2009 | US20090030032 Bicyclic Compound, Production and Use Thereof |
| 01/29/2009 | US20090030002 Heterocyclic compounds and their uses |
| 01/29/2009 | US20090029998 Thiazole Derivatives and Use Thereof |
| 01/29/2009 | US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 01/29/2009 | US20090029994 Trisubstituted amine compound |
| 01/29/2009 | US20090029987 Pharmaceutical Compositions for the Prevention and Treatment of Complex Diseases and Their Delivery by Insertable Medical Devices |
| 01/29/2009 | US20090029985 Pyridazine compounds and methods |
| 01/29/2009 | US20090029984 Synergistic combination for the treatment of pain (cannabinoid receptor agonist and opioid receptor agonist) |
| 01/29/2009 | US20090029970 Pain remedy containing rock inhibitor |
| 01/29/2009 | US20090029969 1-(2,4-dichlorophenyl)-4-methyl-5-(5-(pent-1-enyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide; cannabinoid receptor modulator; liver fibrosis, obesity, type II diabetes, atherosclerosis, analgesia, haemorrhagic shock, ischemia, liver cirrhosis, neurodegenerative diseases |
| 01/29/2009 | US20090029956 Substance mixture |
| 01/29/2009 | US20090029938 Phosphodiesterase inhibitor for treatment and prevention of asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome, bronchitis, chronic bronchitis, silicosis, pulmonary fibrosis, lung allograft rejection, allergic rhinitis and chronic sinusitis |
| 01/29/2009 | US20090029929 Decoy Nucleic Acid to Synoviolin Gene Promoter |
| 01/29/2009 | US20090029908 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 01/29/2009 | US20090029906 Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators |
| 01/29/2009 | US20090028944 Pharmaceutical compositions comprising mesalamine |
| 01/29/2009 | US20090028905 Injecting a Botulinum Toxin into a flexor digitorum profundus muscle of the affected leg of the horse, in an amount insufficient to cause death or paralysis |
| 01/29/2009 | US20090028904 Novel cochleate formulations |
| 01/29/2009 | US20090028883 Novel P-selectin Ligand Protein |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | US20090028875 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response |
| 01/29/2009 | US20090028873 Substituted cyclohexanols |
| 01/29/2009 | US20090028867 Antagonists Specific For Denatured Collagen And Methods Of Using Same |
| 01/29/2009 | US20090028859 Bispecific antibodies that bind to vegf receptors |
| 01/29/2009 | US20090028851 Novel Antibodies Directed to the Mammalian Eag1 Ion Channel Protein |
| 01/29/2009 | US20090028825 Compositions and Methods for Studying and Treating Inflammatory Diseases and Disorders |
| 01/29/2009 | US20090028784 Antibodies to IL-6 and use thereof |
| 01/29/2009 | DE102007035323A1 New diazen-1-ium-1,2-diolate substituted ketoconazole derivatives are ergosterol biosynthesis inhibitors useful as an active agent against microbial pathogenic germs, e.g. fungus, and an antiinflammatory active agent |
| 01/29/2009 | DE102007034976A1 Arzneimittel zur transdermalen Anwendung bei Tieren For transdermal drug use in animals |
| 01/29/2009 | DE102007034620A1 Neue B1-Antagonisten New B1 antagonists |
| 01/29/2009 | CA2731801A1 Therapeutic formulations for the treatment of cold and flu-like symptoms |
| 01/29/2009 | CA2694396A1 Targeted binding agents directed to kdr and uses thereof - 035 |
| 01/29/2009 | CA2694251A1 Novel b1-antagonists |
| 01/29/2009 | CA2692824A1 Novel histidine derivatives |
| 01/28/2009 | EP2019118A1 Method for synthesizing thymosins |
| 01/28/2009 | EP2019098A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor |
| 01/28/2009 | EP2018872A1 Pharmaceutical product |
| 01/28/2009 | EP2018855A1 Pharmaceutical agent |
| 01/28/2009 | EP2018388A2 Bisadenosine compounds as adenosine a2a receptor agonists |
| 01/28/2009 | EP2018387A1 Thiazolyldihydroindazoles |
| 01/28/2009 | EP2018386A1 Thiazolyldihydroindazoles |
| 01/28/2009 | EP2018385A1 Thiazolyl-dihydroquinazolines |
| 01/28/2009 | EP2018382A2 Purine derivatives as adenosine receptor activator |
| 01/28/2009 | EP2018381A2 Use of 2-(purin-9-yl)-tetrahydofuran-3,4-diol derivatives as adenosine a2a receptor agonists |
| 01/28/2009 | EP2018377A1 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. |
| 01/28/2009 | EP2018375A1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. |
| 01/28/2009 | EP2018211A2 Veterinary pharmaceutical compositions for the treatment of pain and inflammation |
| 01/28/2009 | EP2018164A2 Use of combination preparations comprising antifungal agents |
| 01/28/2009 | EP1670761B1 Tetrahydro-naphthalene and urea derivatives |
| 01/28/2009 | EP1541672B1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/28/2009 | EP1470826B1 Decoy-containing pharmaceutical compositions for the treatment of aneurysms |
| 01/28/2009 | EP1435927B1 Use of totarol for the treatment of pruritus |
| 01/28/2009 | EP1207755B1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 01/28/2009 | EP1177181B1 Substituted bicyclic compounds |
| 01/28/2009 | EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 01/28/2009 | CN101356168A Quinazolines useful as modulators of voltage gated ion channels |
| 01/28/2009 | CN101356160A Trisubstituted quinazolinone derivatives as vanilloid antagonists |
| 01/28/2009 | CN101355967A Treating inflammatory disorders with antibodies to the alpha-7 |
| 01/28/2009 | CN101355957A Methods for fusion polypeptide delivery into a cell |
| 01/28/2009 | CN101355947A Thiazolopyrimidines for use in therapy |
| 01/28/2009 | CN101353362A Extraction method of cyaniding 3-0-glucoside |
| 01/28/2009 | CN101353351A Novel 2,3,3a,4-tetrahydro thiochromeno [4,3-c] pyrazole antiinflammatory antimycotic compound |
| 01/28/2009 | CN101352567A Composition for treating ache |
| 01/28/2009 | CN101352541A Medicament and preparation method thereof for treating common diseases in home |
| 01/28/2009 | CN101352540A Nutritive health product and preparation method thereof |
| 01/28/2009 | CN101352531A Medicinal spirit for rheumatism |
| 01/28/2009 | CN101352527A Medicament for treating rheumatic arthritis |
| 01/28/2009 | CN101352517A Chinese medicine for treating lumbocrural pain and preparation method thereof |
| 01/28/2009 | CN101352503A Plaster for treating joint ache and preparation method thereof |
| 01/28/2009 | CN101352501A Chinese medicine for treating traumatic injury and production method |
| 01/28/2009 | CN101352486A Isatis root and astragalus microspheres for injections and preparation method thereof |
| 01/28/2009 | CN101352466A Chinese medicinal composition and uses thereof |
| 01/28/2009 | CN101352462A Chinese actinidia root triterpenes compounds and extracting method thereof |
| 01/28/2009 | CN101352428A Solid preparation containing ibuprofen and tranexamic acid |
| 01/28/2009 | CN101352416A Luteolin solution composition |
| 01/28/2009 | CN101352412A Intestinal-lysis non-steroidal antipyretic-antalgic anti-inflammatory agent and preparation thereof |
| 01/28/2009 | CN101352234A Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 01/28/2009 | CN101352213A Five-color total nutrient rice and production method |
| 01/28/2009 | CN101352192A Ficus carica fruit tea and production method |
| 01/28/2009 | CN100455582C Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 01/28/2009 | CN100455580C Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 01/28/2009 | CN100455571C Kukoline salt compounds and its preparation method |
| 01/28/2009 | CN100455302C Danshen freeze-drying injection for treating cardiovascular and cerebrovascular diseases and preparation thereof |
| 01/28/2009 | CN100455283C Medicine containing acarnine compound as active component |
| 01/28/2009 | CN100455280C An externally applied ointment |
| 01/27/2009 | US7482491 Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 01/27/2009 | US7482458 Quinoline derivatives |
| 01/27/2009 | US7482456 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors |
| 01/27/2009 | US7482436 Human antihuman interleukin-6 antibody and fragment of antibody |
| 01/27/2009 | US7482434 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |